Thus, Paradis et al. demonstrated, both in cell lines and in xenograft and liver MUM models in vivo, that the pharmacological combination of MEK-ERK and FAKi showed a negative synergistic action on cell growth, as well as cytotoxic effects leading to tumour regression [104]. Here, MAP2K7 is linked to neoplasm.